Site Search
Results
-
Meeting Summary of the National Advisory Environmental Health Sciences Council -...
... joining with NIH to study Alzheimer's disease, rheumatoid arthritis, and lupus, with the intent of distinguishing targets of the diseases most likely to respond to therapies. Dr. ...
Size: 1.6MB https://www.niehs.nih.gov/sites/default/files/2025-10/naehs_council_minutes_2014_february_print_508.pdf -
NAEHS Council Update - February 2024
... in Targeted Therapies, The University of Texas MD Anderson Cancer Center, Houston, TX . ... adult dermatomyositis (DM) and juvenile DM patients receiving immunosuppressive therapies. ...
Size: 331KB https://www.niehs.nih.gov/sites/default/files/DIR_February_2024_NAEHS_Council_Update_508.pdf -
NAEHS Council Update - May 2009
... Kyoto, Japan; and Novartis Pharma AG, Basel, Switzerland, studying the physiological functions of retinoid-related orphan receptors in immunity and discovery of potential therapies ...
Size: 227KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/may2009/division_of_intramural_research_naehs_council_update_may2009_508.pdf -
NIEHS Clinical Research Program - May 2009 Update
... as well as the development of clinical tools for assessment of innovative therapies. 9 Appendix 1. Components of the NIEHS Office of Human Research Regulatory Compliance ...
Size: 156KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/may2009/niehs_clinical_research_program_may2009_508.pdf -
NIEHS Office of Communications and Public Liaison (OCPL)
... protein tristetraprolin significantly reduced or protected mice from inflammation, which may lead to effective therapies. o Francesco DeMayo, Ph.D., of DIR, received tenure. . ...
Size: 1.4MB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/may2016/report_from_office_of_communications_and_public_liaison_508.pdf -
Division of Intramural Research - NAEHS Council Update - September 2014
... There is no other tool now available that is as simple, cheap, safe, and readily interpretable. 34 Adgent MA, Flake GP, Umbach DM, Stallings VA, Bernbaum JC, Rogan WJ. Urogenital ...
Size: 305KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/sep2014/sept_2014_naehs_council_update_dir_508.pdf -
Division of Intramural Research NAEHS Council Update, September 2015
... making this enzyme an important target for future cancer therapies and diagnostics. ... These findings might facilitate the design of therapies targeting specific forms of ...
Size: 238KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/sep2015/report_from_division_of_intramural_research_508.pdf -
FY2011 Congressional Justification (full document)
... Funds are included in R&D contracts to support several trans-NIH initiatives, such as the Therapies for Rare and Neglected Diseases program (TRND), the Basic Behavioral and Social ...
Size: 830KB https://www.niehs.nih.gov/sites/default/files/about/congress/justification/2011/2011_congressional_508.pdf -
FY2012 Congressional Justification
... Funds are included in R&D contracts to reflect NIEHS' share of NIH-wide funding required to support several trans-NIH initiatives, such as the Therapies for Rare and Neglected ...
Size: 433KB https://www.niehs.nih.gov/sites/default/files/about/congress/justification/2012/2012_congressional_508.pdf -
Fiscal Year 2016 Congressional Justification
... work contributes to understanding the role of a common variant associated with lupus and provides mechanistic insight that may lead to improved diagnosis or therapies for lupus. ...
Size: 405KB https://www.niehs.nih.gov/sites/default/files/about/congress/justification/2016/2016_congressional_508.pdf
to Top